Growing Pig Incidence Rate, Control and Prevention of Porcine Epidemic Diarrhea Virus in a Large Pig Production System in the United States

Jul 01, 2022

Abstract: Growing pig incidence rate, control and prevention of porcine epidemic diarrhea virus in a large pig production system in the United States

Background: In 2013, PEDV was introduced in the United States (U.S.) and rapidly spread across the country. Here we describe the occurrence of PEDV in the growing pig herd of one large U.S. production system through an active surveillance set in place between October 2019 and November 2020 designed to assess disease status upon placement into the growing pig site, before shipping to the slaughter plant and when diarrhea events were present at the site. We also assessed the impact of preventive procedures implemented in PEDV incidence that comprised site-specific equipment segregation and biosecurity changes regarding personnel movement between sites.
Results: 36.50% (100/274) of the sites had at least one PEDV introduction event before preventive procedures were implemented, yielding an incidence rate of 2.41 per 100 farm-weeks. Most (63/100) of them occurred in sites where animals were placed negative and PEDV was detected in clinical samples in a median of 8 weeks post placement. After preventive procedures were implemented, the overall PEDV incidence rate dropped to 0.37 per 100 farm-weeks (84.65% reduction, p < 0.001).

Click here to see more...

Video: Four Star Pork Industry Conf - Back to Basics: Fundamentals drive vaccine performance

At a time when disease pressure continues to challenge pork production systems across the United States, vaccination remains one of the most valuable and heavily debated tools available to veterinarians and producers.

Speaking at the 2025 Four Star Pork Industry Conference in Muncie, Indiana, Dr. Daniel Gascho, veterinarian at Four Star Veterinary Service, encouraged the industry to return to fundamentals in how vaccines are selected, handled and administered across sow farms, gilt development units and grow-finish operations.

Gascho acknowledged at the outset that vaccination can quickly become a technical and sometimes tedious topic. But he said that real-world execution, not complex immunology, is where most vaccine failures occur.